|
HS Code |
180018 |
| Product Name | Boc-L-2-Methylphe |
| Chemical Formula | C16H23NO4 |
| Purity | ≥98% |
| Appearance | White to off-white solid |
| Cas Number | 16652-46-9 |
| Storage Temperature | 2-8°C |
| Solubility | Soluble in DMSO, DMF |
| Functional Group | Boc-protected amino acid |
| Optical Activity | L-isomer |
| Application | Peptide synthesis |
| Synonyms | Boc-L-2-Methylphenylalanine |
| Smiles | CC1=CC=CC=C1C[C@H](N)C(=O)OCC(C)(C)C |
| Shelf Life | 24 months |
As an accredited Boc-L-2-Methylphe factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | Boc-L-2-Methylphe is packaged in a 5g amber glass bottle, sealed, with clear labeling for safe chemical storage and handling. |
| Shipping | Boc-L-2-Methylphe is shipped in secure, chemical-resistant containers to ensure stability and prevent contamination. The package is clearly labeled and accompanied by a Safety Data Sheet (SDS). Shipping complies with regulatory guidelines for hazardous materials, utilizing expedited, temperature-controlled methods if required for product preservation during transit. |
| Storage | Boc-L-2-Methylphe should be stored in a tightly sealed container, protected from light and moisture. Keep at 2-8°C (refrigerated) in a well-ventilated area away from incompatible substances such as strong oxidizing agents. Ensure proper labeling and avoid prolonged exposure to air. Store in a designated chemical storage area intended for amino acid derivatives and peptide synthesis reagents. |
Applications of Boc-L-2-Methylphe in Industrial ManufacturingBoc-L-2-Methylphenylalanine serves as a key protected amino acid for chemical synthesis workflows in pharmaceutical, peptide, and advanced material manufacturing. Our factory supports customers with precise matching to their target downstream processes, ensuring consistent compliance, integration, and performance across specialized industrial sectors. 1. Pharmaceutical API Peptide SynthesisPeptide drug developers rely on Boc-L-2-Methylphe during solid-phase peptide synthesis (SPPS) to introduce site-specific methyl-phenylalanine residues, which modify pharmacokinetics and molecular stability. The raw material is directly coupled using Fmoc/Boc strategies on resin, requiring high purity and batch consistency due to downstream registration with global regulatory agencies. Manufacturers must maintain traceable supply chains and full analytical provenance, as product qualification is mandatory for IND filings and eventual commercial scale-up in GMP environments. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
2. High-Purity Peptide Reagent ProductionChemical research suppliers utilize Boc-L-2-Methylphe to manufacture protected amino acid reagent kits for academic, biotech, and high-throughput screening facilities. This application demands small-scale, ultra-high-purity output, especially for delivery to regulated campus and clinical development labs. Precision in packing, labeling, and chain-of-custody documentation remains critical as these reagents feed directly into quality-controlled discovery workflows and analytical method development. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
3. Peptide-Based Diagnostic Reagent ManufacturingIn vitro diagnostic (IVD) manufacturers incorporate Boc-L-2-Methylphe during the controlled synthesis of peptide markers used in immunoassays and companion diagnostic kits. The amino acid's steric and chemical features enhance selectivity for antibody binding or enzymatic assay formats, requiring consistent lot-to-lot performance and adherence to medical device production codes. Trace-level impurity control directly influences product release and regulatory submission outcomes. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
4. Custom Peptidomimetic Compound SynthesisBiotech firms and specialist CROs select Boc-L-2-Methylphe as a core structural unit in the design of novel peptidomimetics, especially where steric hindrance and side chain engineering enhance metabolic stability or receptor selectivity. Chemists introduce the compound at precise linear or cyclic sequence positions, with custom protocols for cleavage, purification, and final characterization. Integration with industrial-scale preparative HPLC and mass-directed fractionation is a production requirement. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
|
Competitive Boc-L-2-Methylphe prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please call us at +8615371019725 or mail to admin@sinochem-nanjing.com.
We will respond to you as soon as possible.
Tel: +8615371019725
Email: admin@sinochem-nanjing.com
Flexible payment, competitive price, premium service - Inquire now!
In our work, every new amino acid derivative comes with its own set of challenges and opportunities. Among these, Boc-L-2-Methylphe holds a special place. Years of hands-on process development guide our current production methods for this protected amino acid, ensuring each batch supports demanding peptide syntheses. We see Boc-L-2-Methylphe not just as a stock-keeping unit, but as a bridge between fundamental chemistry and complex applications, proven repeatedly by feedback from peptide researchers and process chemists who rely on batch-to-batch consistency.
Making Boc-L-2-Methylphe, or N-Boc-L-2-Methylphenylalanine, requires more than just following a recipe. We put our chemists’ know-how to the test with every synthesis cycle, because this molecule carries a methyl group at the 2-position of the aromatic ring—a structural difference that brings new reactivity to peptide design. It’s chosen for precisely this reason: the side-chain methyl group changes the way peptides fold, interact, and behave, which matters in both discovery and scale-up projects.
Handling the steric demands of 2-methyl substitution, along with keeping optical purity high, influences each stage from raw material inspection to purification. Not every protected phenylalanine derivative behaves like Boc-L-2-Methylphe. Any lab technician running a peptide coupling involving this building block notices that slight adjustments often make a meaningful difference: coupling rates, racemization sensitivity, and solubility all change. We didn’t just read this in a paper; we adjust our protocols over years, adapting to these quirks to make sure we meet real-world expectations.
Our batches of Boc-L-2-Methylphe keep moisture and residual solvent to threshold levels supported by method validation, not just by default. We regularly conduct Karl Fischer and GC checks because experience taught us that even a small shift in drying protocol affects downstream peptide yields. You can see this in how powders behave upon storage, especially in humid conditions. Stability studies, undertaken over years of fulfilling orders through all seasons, gave us insight into both short-term reactivity and long-term storage.
The observed melting point range and specific rotation have been used as batch acceptance criteria since initial scale-up. These physical fingerprints speak volumes for those who have struggled with inconsistent raw materials. Purity is tracked by HPLC, but the thresholds we set come from actual feedback loops: when a research partner flagged a run of off-purity material years ago, our laboratory spent weeks identifying and solving the underlying process deviation, rewriting our internal procedures. Contaminants seen as “trace” by other producers can easily induce failures in solid-phase peptide synthesis. That’s why we set detection limits and train staff to catch them.
Boc-L-2-Methylphe isn’t a mass-market bulk chemical; its value comes from targeted peptide or small-molecule projects. Researchers use it for custom peptide sequences, especially where side-chain sterics influence activity. In one case, a team using our product in combinatorial chemistry reported that the introduction of the 2-methyl group adjusted the overall conformation of their libraries, providing binding selectivity they hadn’t seen with unmodified phenylalanine. We discuss these effects openly, pointing out where the unique properties either solve a problem or call for workaround.
The majority of customers come from pharmaceutical R&D labs and peptide foundries. These partners appreciate open communication about handling. Unlike some protected amino acids, Boc-L-2-Methylphe tends to be less soluble in certain polar organic solvents. Our technical notes cover these points because we troubleshoot daily with teams who want to avoid clogs in automated synthesizers or manage deprotection byproducts efficiently. Purification, too, plays a role: 2-methyl substitution modestly alters polarity, so our experience helps end users tune their purification steps.
Some groups are pushing boundaries by using Boc-L-2-Methylphe in cyclic peptides, where backbone rigidity is crucial. Others pursue it as a key fragment for pharmaceuticals under patent or in early-stage lead development. In each scenario, mistakes in protecting group integrity or stereochemistry cause costly rework. Over time, we’ve learned to be transparent about batch-to-batch minor differences, offering complete profiles so users stay a step ahead.
Every kilogram of Boc-L-2-Methylphe passes through equipment calibrated for multi-step organic synthesis, not just blending. Starting from L-2-Methylphenylalanine—purchased at specification and identity-verified in-house—each transformation leading to Boc-protection must balance yield, purity, and environmental control. Older process routes used traditional solvents, but we switched to more sustainable alternatives once we proved they didn’t compromise critical quality attributes.
Operator skill plays a big part. Even the timing for introducing Boc-anhydride makes a difference, especially as the sterics from the methyl group slow down some acylation kinetics. Our technical team documents every change, monitors exotherms during scale-up, and tracks even minor byproduct levels because they can impact peptide coupling downstream. No two runs are exactly alike—our records from past batches document lessons learned across seasons, supply chain variations, and reactor swaps.
Purification comes next. We invested in column chromatography and final recrystallization setups that match the needs of moderately lipophilic, low-volatility powders like Boc-L-2-Methylphe. Waste minimization also factors in: organic byproducts are separated and sent for responsible disposal. Solvent recovery incorporates both regulatory and practical feedback, shaped by routine inspection and the reality of rising solvent costs. Our laboratory staff reviews every analytical result on finished lots so R&D projects relying on our deliveries aren’t disrupted by residue issues.
Our QA/QC protocols didn’t come from handbooks—they evolved with feedback from researchers who discovered that even a slight residue of unreacted Boc-anhydride or a misjudged water wash could spell confusion when quantifying final purity. Years ago, a failed batch identified through outside lab retesting made us trace every process variable, leading us to rework our documentation entirely. Every report now includes full lot characterization and impurity profiling following up-to-date instrumental standards.
Users often ask how Boc-L-2-Methylphe stands next to more familiar materials like Boc-L-phenylalanine or Boc-L-2,6-dimethylphenylalanine. From our perspective, the side-chain methyl group impacts not just molecular recognition, but also handling at every stage—this isn’t academic, it’s rooted in years of repeated production. Yields may drop slightly due to increased steric hindrance in protection and coupling steps, so we set up longer reaction periods and more rigorous in-process control checks.
Compared to Boc-L-phenylalanine, every round of process control becomes more sensitive for Boc-L-2-Methylphe. The methyl group at the 2-position changes the molecule’s behavior in solvent systems, particularly during chromatographic purification. Our in-house analytics show altered retention times, demanding a fine-tuned mobile phase. Development chemists using this product in peptide synthesis notice that coupling rates with some resins slow down, occasionally requiring modified activation chemistry—information we document in technical summaries based on first-hand batch production data.
By comparison, Boc-L-2,6-dimethylphenylalanine requires even more stringent purification because double methylation brings added challenges in solubility and isolation. But many users prefer Boc-L-2-Methylphe because it offers a measured step up in steric differentiation without reaching the complexity of the dimethyl analog. Understanding these gradations helped us advise customers in pharmaceutical discovery, letting them weigh options based on performance, analytic simplicity, and budget.
Direct engagement with experienced customers drives our improvements. A peptide synthesis lab once requested a bespoke delivery: an ultra-low impurity variant to meet next-generation analytical standards. Our answer didn’t come off a spec sheet—it required re-tuning our purification to reduce trace organics and water content, followed by revalidation of stability studies. That challenge led us to implement real-time environmental monitoring and up-to-date analytics for every batch, giving peace of mind to clients working in regulated environments.
We like to hear when a regular customer pushes us with their constraints, whether it involves changing package sizes or accommodating higher throughput. It’s that back-and-forth that led to packaging improvements—triple-layered, moisture-resistant containers that don’t cling to the technical powder—and new stockkeeping protocols that cut delivery times. Most adaptations are possible because of an on-site team that knows both the chemistry and the practical bottlenecks labs face. Working closely with chemists at universities or pharmaceutical firms, we shortlist changes only after seeing performance in real-world trial syntheses, not just pilot batches.
Every ampule or drum bears a lot sheet detailing real analysis runs, not just typewritten summaries. Chromatograms, water assays, NMR data, and optical rotation records all go out with each shipment—if any anomaly appears, our technical team is ready to talk directly with the bench chemist or project manager who will use the compound. We found that communicating detailed information—beyond marketing leaflets—lets users cut troubleshooting time and focus on results.
Our in-house technical experts stay alert for literature updates or regulatory revisions, ensuring we comply with evolving regional and global standards. When a peptide project in an overseas pharmaceutical lab faces a regulatory audit, our documentation and chain-of-custody data stand up because they’re born from our own operation, not a third-party repackager. Some customers, working toward investigational new drugs, need assurances on allergens, residual metals, or cross-contaminants—our plant policies specifically address these hotspots, and we revise our SOPs whenever a request highlights an overlooked risk.
Sourcing, handling, and synthesizing protected amino acids like Boc-L-2-Methylphe delivers a constant lesson: nearly every improvement comes from close attention to users’ real problems. Storage stability gets tested every winter and summer; supply timelines are judged in hours, not weeks. Each time a new researcher raises a technical question—about reaction compatibility, or about avoiding aggregation in a peptide step—we feed that directly back into our next process run.
We match this interactive change cycle with regular lab meetings, where production and technical staff debate every reported anomaly. In a recent example, a client’s issue with color change on storage pointed us to refine our final drying step. Small changes, like tweaking nitrogen purge speeds or adjusting crystal morphology through solvent selection, result in noticeable boosts in usability for the purchaser. The product may not be a commodity, but it gets the focus of an artisan bakery—always seeking consistency and depth, batch after batch.
Sustainability is increasingly part of every operator’s daily checklist. We took early steps to reduce solvent emissions, recover and treat waste streams, and select greener raw material sources. Compliance audits don’t just come from outside—our facility standards have been shaped by internal improvement rounds, as well as surprise inspections by research partners who want transparency before including our ingredients in regulated pipelines.
Handling Boc-L-2-Methylphe carries the same precautions as any other fine chemical: dust control, proper containment, and rapid cleanup of any spills. Our operators use PPE and containment best practices, based on chemical risk and air quality reviews, rather than generic staff protocols. All process steps run under documented SOPs upgraded whenever we spot an opportunity for a safer, smoother run.
The landscape of protected building blocks keeps evolving, and Boc-L-2-Methylphe will likely hold its advantages for cycles to come. Labs working on cutting-edge peptide or protein work are already looking for the next increment in structural analogs, but few side-chain modifications strike the compromise between increased steric demand and manageable synthesis like the 2-methyl group does on phenylalanine. Our manufacturing process builds on this, focusing on traits that matter most—clarity in specification, reliability in application, and transparency in communication.
As demand grows for customizable, reliable amino acid derivatives, we stay committed to refining every facet of production and user support. This product has earned its place in the toolkit of chemists who seek not just a molecule, but a partner in development. We will remain actively involved with customers, projects, and cutting-edge synthesis, and continue to let real-world feedback guide all future improvements. Whether working in a startup lab or established pharmaceutical plant, users of Boc-L-2-Methylphe know that quality doesn't come from shortcuts—only diligence, experience, and honest dialogue deliver a product fit for discovery.